Comparability of clinical trials and spontaneous reporting data regarding COVID-19 vaccine safety

Severe adverse events (AEs) after COVID-19 vaccination are not well studied in randomized controlled trials (RCTs) due to rarity and short follow-up. To monitor the safety of COVID-19 vaccines (“Pfizer” vaccine dose 1 and 2, “Moderna” vaccine dose 1 and 2, and “Janssen” vaccine single dose) in the U...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Chongliang, Du, Jingcheng, Cuker, Adam, Lautenbach, Ebbing, Asch, David A., Poland, Gregory A., Tao, Cui, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243073/
https://www.ncbi.nlm.nih.gov/pubmed/35768434
http://dx.doi.org/10.1038/s41598-022-13809-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243073/
https://www.ncbi.nlm.nih.gov/pubmed/35768434
http://dx.doi.org/10.1038/s41598-022-13809-7

Ejemplares similares